{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:47:42Z","timestamp":1782089262298,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-10074-6","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T18:17:28Z","timestamp":1776709048000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Zinc-dependent Zip7-MAZ-MYBL2 axis promotes prostate cancer metastasis"],"prefix":"10.1038","volume":"9","author":[{"given":"Qianxi","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Situ","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruize","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangpeng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongji","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuchun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6686-7561","authenticated-orcid":false,"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0460-8951","authenticated-orcid":false,"given":"Songhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0881-0936","authenticated-orcid":false,"given":"Ju","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"10074_CR1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403331121","volume":"121","author":"M Pornour","year":"2024","unstructured":"Pornour, M. et al. USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity. Proc. Natl. Acad. Sci. USA 121, e2403331121 (2024).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10074_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18511","volume":"28","author":"H Jiang","year":"2024","unstructured":"Jiang, H. et al. Identification of prostate cancer bone metastasis related genes and potential therapy targets by bioinformatics and in vitro experiments. J. Cell Mol. Med. 28, e18511 (2024).","journal-title":"J. Cell Mol. Med."},{"key":"10074_CR3","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.clinbiochem.2005.11.018","volume":"39","author":"A Aydin","year":"2006","unstructured":"Aydin, A. et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin. Biochem. 39, 176\u2013179 (2006).","journal-title":"Clin. Biochem."},{"key":"10074_CR4","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.abb.2016.04.014","volume":"611","author":"LC Costello","year":"2016","unstructured":"Costello, L. C. & Franklin, R. B. A comprehensive review of the role of zinc in normal prostate function and metabolism; and its implications in prostate cancer. Arch. Biochem. biophys. 611, 100\u2013112 (2016).","journal-title":"Arch. Biochem. biophys."},{"key":"10074_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00775-010-0736-9","volume":"16","author":"LC Costello","year":"2011","unstructured":"Costello, L. C. & Franklin, R. B. Zinc is decreased in prostate cancer: an established relationship of prostate cancer! J. Biol. Inorg. Chem. 16, 3\u20138 (2011).","journal-title":"J. Biol. Inorg. Chem."},{"key":"10074_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-4-32","volume":"4","author":"RB Franklin","year":"2005","unstructured":"Franklin, R. B. et al. hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer. Mol. Cancer 4, 32 (2005).","journal-title":"Mol. Cancer"},{"key":"10074_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/BF02552202","volume":"29","author":"V Zaichick","year":"1997","unstructured":"Zaichick, V., Sviridova, T. V. & Zaichick, S. V. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int. Urol. Nephrol. 29, 565\u2013574 (1997).","journal-title":"Int. Urol. Nephrol."},{"key":"10074_CR8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1002\/(SICI)1097-0045(19980601)35:4<285::AID-PROS8>3.0.CO;2-F","volume":"35","author":"LC Costello","year":"1998","unstructured":"Costello, L. C. & Franklin, R. B. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer.  Prostate 35, 285\u2013296 (1998).","journal-title":"Prostate"},{"key":"10074_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/oxfordjournals.epirev.a000801","volume":"23","author":"EA Platz","year":"2001","unstructured":"Platz, E. A. & Helzlsouer, K. J. Selenium, zinc, and prostate cancer. Epidemiol. Rev. 23, 93\u2013101 (2001).","journal-title":"Epidemiol. Rev."},{"key":"10074_CR10","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/1097-0142(19890401)63:7<1388::AID-CNCR2820630725>3.0.CO;2-M","volume":"63","author":"JO Ogunlewe","year":"1989","unstructured":"Ogunlewe, J. O. & Osegbe, D. N. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate. Cancer 63, 1388\u20131392 (1989).","journal-title":"Cancer"},{"key":"10074_CR11","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/BF02552165","volume":"28","author":"VY Zaichick","year":"1996","unstructured":"Zaichick, V. Y., Sviridova, T. V. & Zaichick, S. V. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma and cancer. Int. Urol. Nephrol. 28, 687\u2013694 (1996).","journal-title":"Int. Urol. Nephrol."},{"key":"10074_CR12","doi-asserted-by":"crossref","unstructured":"Li, D., Stovall, D. B., Wang, W. & Sui, G. Advances of zinc signaling studies in prostate cancer. Int. J. Mol. Sci. 21, 667 (2020).","DOI":"10.3390\/ijms21020667"},{"key":"10074_CR13","doi-asserted-by":"crossref","unstructured":"Portbury, S. D. & Adlard, P. A. Zinc signal in brain diseases. Int. J. Mol. Sci. 18, 2506 (2017).","DOI":"10.3390\/ijms18122506"},{"key":"10074_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1152\/physrev.00035.2014","volume":"95","author":"T Kambe","year":"2015","unstructured":"Kambe, T., Tsuji, T., Hashimoto, A. & Itsumura, N. The physiological, biochemical, and molecular roles of zinc transporters in zinc homeostasis and metabolism. Physiol. Rev. 95, 749\u2013784 (2015).","journal-title":"Physiol. Rev."},{"key":"10074_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep36772","volume":"6","author":"CK Singh","year":"2016","unstructured":"Singh, C. K. et al. Analysis of Zinc-Exporters Expression in Prostate Cancer. Sci. Rep. 6, 36772 (2016).","journal-title":"Sci. Rep."},{"key":"10074_CR16","doi-asserted-by":"publisher","first-page":"24085","DOI":"10.1074\/jbc.R600011200","volume":"281","author":"RJ Cousins","year":"2006","unstructured":"Cousins, R. J., Liuzzi, J. P. & Lichten, L. A. Mammalian zinc transport, trafficking, and signals.  J. Biol. Chem. 281, 24085\u201324089 (2006).","journal-title":"J. Biol. Chem."},{"key":"10074_CR17","doi-asserted-by":"publisher","first-page":"e1006349","DOI":"10.1371\/journal.pgen.1006349","volume":"12","author":"W Ohashi","year":"2016","unstructured":"Ohashi, W. et al. Zinc transporter SLC39A7\/ZIP7 promotes intestinal epithelial self-renewal by resolving ER stress. PLoS Genet. 12, e1006349 (2016).","journal-title":"PLoS Genet."},{"key":"10074_CR18","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1242\/dev.088336","volume":"140","author":"C Groth","year":"2013","unstructured":"Groth, C., Sasamura, T., Khanna, M. R., Whitley, M. & Fortini, M. E. Protein trafficking abnormalities in Drosophila tissues with impaired activity of the ZIP7 zinc transporter Catsup. Development 140, 3018\u20133027 (2013).","journal-title":"Development"},{"key":"10074_CR19","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/abbs\/gmx094","volume":"49","author":"N Sheng","year":"2017","unstructured":"Sheng, N. et al. Knockdown of SLC39A7 inhibits cell growth and induces apoptosis in human colorectal cancer cells. Acta Biochim. Biophys. Sin. 49, 926\u2013934 (2017).","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10074_CR20","first-page":"1165","volume":"16","author":"Y Wei","year":"2017","unstructured":"Wei, Y., Dong, J., Li, F., Wei, Z. & Tian, Y. Knockdown of SLC39A7 suppresses cell proliferation, migration and invasion in cervical cancer. EXCLI J. 16, 1165\u20131176 (2017).","journal-title":"EXCLI J."},{"key":"10074_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molmed.2009.01.004","volume":"15","author":"C Hogstrand","year":"2009","unstructured":"Hogstrand, C., Kille, P., Nicholson, R. I. & Taylor, K. M. Zinc transporters and cancer: a potential role for ZIP7 as a hub for tyrosine kinase activation. Trends Mol. Med. 15, 101\u2013111 (2009).","journal-title":"Trends Mol. Med."},{"key":"10074_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217201","volume":"602","author":"J Zeng","year":"2024","unstructured":"Zeng, J. et al. MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1\/2 activation. Cancer Lett. 602, 217201 (2024).","journal-title":"Cancer Lett."},{"key":"10074_CR23","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.2174\/0115680096265896231226062212","volume":"24","author":"F Zhang","year":"2024","unstructured":"Zhang, F. et al. Transcription factor MAZ potentiates the upregulated NEIL3-mediated aerobic glycolysis, thereby promoting angiogenesis in hepatocellular carcinoma. Curr. Cancer Drug Targets 24, 1235\u20131249 (2024).","journal-title":"Curr. Cancer Drug Targets"},{"key":"10074_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.canlet.2017.05.020","volume":"402","author":"ZH Yu","year":"2017","unstructured":"Yu, Z. H. et al. Dual function of MAZ mediated by FOXF2 in basal-like breast cancer: Promotion of proliferation and suppression of progression. Cancer Lett. 402, 142\u2013152 (2017).","journal-title":"Cancer Lett."},{"key":"10074_CR25","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1074\/jbc.RA117.000333","volume":"293","author":"G Maity","year":"2018","unstructured":"Maity, G. et al. The MAZ transcription factor is a downstream target of the oncoprotein Cyr61\/CCN1 and promotes pancreatic cancer cell invasion via CRAF-ERK signaling.  J. Biol. Chem. 293, 4334\u20134349 (2018).","journal-title":"J. Biol. Chem."},{"key":"10074_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s13046-019-1374-x","volume":"38","author":"Q Yang","year":"2019","unstructured":"Yang, Q. et al. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway. J. Exp. Clin. Cancer Res. 38, 391 (2019).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10074_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0570-3","volume":"30","author":"L Jiao","year":"2013","unstructured":"Jiao, L. et al. The prostate cancer-up-regulated Myc-associated zinc-finger protein (MAZ) modulates proliferation and metastasis through reciprocal regulation of androgen receptor. Med. Oncol. 30, 570 (2013).","journal-title":"Med. Oncol."},{"key":"10074_CR28","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1006\/bcmd.2001.0399","volume":"27","author":"M Bessa","year":"2001","unstructured":"Bessa, M., Joaquin, M., Tavner, F., Saville, M. K. & Watson, R. J. Regulation of the cell cycle by B-Myb. Blood Cells Mol. Dis. 27, 416\u2013421 (2001).","journal-title":"Blood Cells Mol. Dis."},{"key":"10074_CR29","first-page":"2451","volume":"59","author":"E Grassilli","year":"1999","unstructured":"Grassilli, E., Salomoni, P., Perrotti, D., Franceschi, C. & Calabretta, B. Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction. Cancer Res. 59, 2451\u20132456 (1999).","journal-title":"Cancer Res."},{"key":"10074_CR30","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/onc.2009.22","volume":"28","author":"AS Knight","year":"2009","unstructured":"Knight, A. S., Notaridou, M. & Watson, R. J. A Lin-9 complex is recruited by B-Myb to activate transcription of G2\/M genes in undifferentiated embryonal carcinoma cells. Oncogene 28, 1737\u20131747 (2009).","journal-title":"Oncogene"},{"key":"10074_CR31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/onc.2008.430","volume":"28","author":"AR Thorner","year":"2009","unstructured":"Thorner, A. R. et al. In vitro and in vivo analysis of B-Myb in basal-like breast cancer. Oncogene 28, 742\u2013751 (2009).","journal-title":"Oncogene"},{"key":"10074_CR32","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/j.ejca.2005.08.004","volume":"41","author":"A Sala","year":"2005","unstructured":"Sala, A. B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur. J. cancer 41, 2479\u20132484 (2005).","journal-title":"Eur. J. cancer"},{"key":"10074_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12071-2","volume":"10","author":"J Musa","year":"2019","unstructured":"Musa, J. et al. Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes. Nat. Commun. 10, 4128 (2019).","journal-title":"Nat. Commun."},{"key":"10074_CR34","doi-asserted-by":"publisher","first-page":"7452","DOI":"10.1073\/pnas.89.16.7452","volume":"89","author":"SA Bossone","year":"1992","unstructured":"Bossone, S. A., Asselin, C., Patel, A. J. & Marcu, K. B. MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination. Proc. Natl. Acad. Sci. USA 89, 7452\u20137456 (1992).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10074_CR35","doi-asserted-by":"publisher","first-page":"86420","DOI":"10.18632\/oncotarget.13416","volume":"7","author":"W Luo","year":"2016","unstructured":"Luo, W. et al. MYC associated zinc finger protein promotes the invasion and metastasis of hepatocellular carcinoma by inducing epithelial mesenchymal transition. Oncotarget 7, 86420\u201386432 (2016).","journal-title":"Oncotarget"},{"key":"10074_CR36","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.4161\/cc.20414","volume":"11","author":"KM Taylor","year":"2012","unstructured":"Taylor, K. M., Kille, P. & Hogstrand, C. Protein kinase CK2 opens the gate for zinc signaling. Cell Cycle 11, 1863\u20131864 (2012).","journal-title":"Cell Cycle"},{"key":"10074_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10534-007-9129-0","volume":"21","author":"AL Albrecht","year":"2008","unstructured":"Albrecht, A. L., Somji, S., Sens, M. A., Sens, D. A. & Garrett, S. H. Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line. Biometals 21, 405\u2013416 (2008).","journal-title":"Biometals"},{"key":"10074_CR38","doi-asserted-by":"publisher","first-page":"4912","DOI":"10.1210\/en.2008-0351","volume":"149","author":"KM Taylor","year":"2008","unstructured":"Taylor, K. M. et al. ZIP7-mediated intracellular zinc transport contributes to aberrant growth factor signaling in antihormone-resistant breast cancer Cells. Endocrinology 149, 4912\u20134920 (2008).","journal-title":"Endocrinology"},{"key":"10074_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10549-007-9765-7","volume":"111","author":"X Wang","year":"2008","unstructured":"Wang, X. et al. MAZ drives tumor-specific expression of PPAR gamma 1 in breast cancer cells. Breast Cancer Res. Treat. 111, 103\u2013111 (2008).","journal-title":"Breast Cancer Res. Treat."},{"key":"10074_CR40","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1096\/fj.11-202820","volume":"26","author":"M Smits","year":"2012","unstructured":"Smits, M. et al. Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma. FASEB J. 26, 2639\u20132647 (2012).","journal-title":"FASEB J."},{"key":"10074_CR41","doi-asserted-by":"publisher","first-page":"ra11","DOI":"10.1126\/scisignal.2002585","volume":"5","author":"KM Taylor","year":"2012","unstructured":"Taylor, K. M., Hiscox, S., Nicholson, R. I., Hogstrand, C. & Kille, P. Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7. Sci. Signal. 5, ra11 (2012).","journal-title":"Sci. Signal."},{"key":"10074_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32067-0","volume":"8","author":"H Mnatsakanyan","year":"2018","unstructured":"Mnatsakanyan, H., Serra, R. S. I., Rico, P. & Salmeron-Sanchez, M. Zinc uptake promotes myoblast differentiation via Zip7 transporter and activation of Akt signalling transduction pathway. Sci. Rep. 8, 13642 (2018).","journal-title":"Sci. Rep."},{"key":"10074_CR43","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.7150\/thno.56604","volume":"11","author":"Q Li","year":"2021","unstructured":"Li, Q. et al. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer. Theranostics 11, 5794\u20135812 (2021).","journal-title":"Theranostics"},{"key":"10074_CR44","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1002\/1878-0261.13314","volume":"16","author":"Y Yoshikawa","year":"2022","unstructured":"Yoshikawa, Y. et al. Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer. Mol. Oncol. 16, 3994\u20134010 (2022).","journal-title":"Mol. Oncol."},{"key":"10074_CR45","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1158\/0008-5472.CAN-10-1008","volume":"70","author":"SK Ghosh","year":"2010","unstructured":"Ghosh, S. K. et al. A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing. Cancer Res. 70, 6119\u20136127 (2010).","journal-title":"Cancer Res."},{"key":"10074_CR46","doi-asserted-by":"publisher","first-page":"15788","DOI":"10.1021\/ja807156b","volume":"130","author":"XA Zhang","year":"2008","unstructured":"Zhang, X. A., Hayes, D., Smith, S. J., Friedle, S. & Lippard, S. J. New strategy for quantifying biological zinc by a modified zinpyr fluorescence sensor. J. Am. Chem. Soc. 130, 15788\u201315789 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"10074_CR47","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41589-018-0200-7","volume":"15","author":"E Nolin","year":"2019","unstructured":"Nolin, E. et al. Discovery of a ZIP7 inhibitor from a Notch pathway screen. Nat. Chem. Biol. 15, 179\u2013188 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"10074_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-38596-7","volume":"13","author":"Q Tong","year":"2023","unstructured":"Tong, Q. et al. NVS-ZP7-4 inhibits hepatocellular carcinoma tumorigenesis and promotes apoptosis via PI3K\/AKT signaling. Sci. Rep. 13, 11795 (2023).","journal-title":"Sci. Rep."},{"key":"10074_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41585-021-00438-4","volume":"18","author":"KT Schmidt","year":"2021","unstructured":"Schmidt, K. T., Huitema, A. D. R., Chau, C. H. & Figg, W. D. Resistance to second-generation androgen receptor antagonists in prostate cancer. Nat. Rev. Urol. 18, 209\u2013226 (2021).","journal-title":"Nat. Rev. Urol."},{"key":"10074_CR50","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1038\/s41388-024-03120-2","volume":"43","author":"S Xiong","year":"2024","unstructured":"Xiong, S. et al. A noncanonical E3 ubiquitin ligase RNF41-mediated MYO1C stability promotes prostate cancer metastasis by inducing actin remodeling. Oncogene 43, 2696\u20132707 (2024).","journal-title":"Oncogene"},{"key":"10074_CR51","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1158\/0008-5472.CAN-20-0233","volume":"80","author":"S Xu","year":"2020","unstructured":"Xu, S. et al. p300-mediated acetylation of histone demethylase JMJD1A prevents its degradation by ubiquitin ligase STUB1 and enhances its activity in prostate cancer. Cancer Res. 80, 3074\u20133087 (2020).","journal-title":"Cancer Res."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10074-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10074-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10074-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:02:38Z","timestamp":1782086558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10074-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10074"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10074-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"850"}}